Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004328938 | SCV003989284 | uncertain significance | not specified | 2023-06-02 | criteria provided, single submitter | clinical testing | The c.1666A>G (p.I556V) alteration is located in exon 14 (coding exon 13) of the PIWIL3 gene. This alteration results from a A to G substitution at nucleotide position 1666, causing the isoleucine (I) at amino acid position 556 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |